RE: Patent Expiring"Did plenty of DD". If you did "do plenty", it wasn't enough. Cryocor's response to the lawsuit is irrelevent, even if it's a countersuit; the court's response is the only thing that matters, and that will probably be at least a year from now, at which point appeals will probably extend the issue another year. "Cryocor will be able to proceed with both linear and cryballoon therapy "-----you are delusional. Cryocor has almost nothing in the cryoballoon patent area, while both CYT and BSX have acres of paper, in the space. Should Cryocor try to enter the cryoballoon area, BOTH CYT and BSX would promptly file suit, against a company with almost no revenue, and little chance of seeing much (where is the CRYO installed base ?), within three years. It would be normal behavior for BSX to sign a console development agreement with CRYO that allows CRYO to develop their own cryoballoon, and then file against CRYO, if they tried to bring one to market. Now, when are you going to answer the threat posed by STXS, in the point to point area ? CRYO is pursuing an alternative (to RF) point to point approval, already made irrelevent, by STXS, and CRYO is at least three years behind CYT, in the cryoballoon space. Jan K., who is ten times more qualified than you or I, to judge where the AF interventional treatment area is going, chose CYT. Think about it.